{"title":"1990年至2021年前列腺癌负担趋势和危险因素:对2021年全球疾病负担研究的系统分析","authors":"Yuan Xu, Ruilin Li, Ning Wang, Yan Guo, Chang Wang, Qinduo Ren, Songlin Lu, Shuo Bi, Hongsheng Tian, Xuying Guo, Yuping Zou, Linna Yuan, Wei She, Hongmei Sun, Yu Dong, Chen Zhang, Ye Ma, Zhenwei Shang, Yongshuai Jiang, Wenhua Lv, Hongchao Lv, Mingming Zhang","doi":"10.1080/14737140.2025.2555466","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Prostate cancer (PCa) is one of the most common malignancies in males worldwide. Therefore, conducting the latest and comprehensive assessment of PCa is important.</p><p><strong>Research design and methods: </strong>Average annual percent change for age-standardized rate trend was calculated by Joinpoint. Pearson correlation analyzed the relationship between PCa and Sociodemographic Index (SDI). Causal associations of risk factors were examined by two-sample mendelian randomization. Bayesian age-period-cohort model was used to predict incidence trends to 2050.</p><p><strong>Results: </strong>In 2021, the global incidence of PCa was 1,324,383, an increase of 161.53% since 1990. It was mainly concentrated in the age group of 65-79. From 1990 to 2021, the global incidence and prevalence increased slightly. PCa was more common in regions with a high SDI. Mortality was the highest in regions with a low SDI. Smoking and telomere length were found to be risk factors for PCa, and diet low in calcium and milk was also related to PCa. The prediction results revealed that the incidence of PCa will slightly decrease in the future.</p><p><strong>Conclusions: </strong>The disease burden of PCa gradually increased from 1990 to 2021. There were significant differences across countries, SDI regions, and age groups. By 2050, the incidence of this disease is expected to decrease.</p>","PeriodicalId":12099,"journal":{"name":"Expert Review of Anticancer Therapy","volume":" ","pages":"1-10"},"PeriodicalIF":2.8000,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Burden trends and risk factors for prostate cancer from 1990 to 2021: a systematic analysis of the Global Burden of Disease Study 2021.\",\"authors\":\"Yuan Xu, Ruilin Li, Ning Wang, Yan Guo, Chang Wang, Qinduo Ren, Songlin Lu, Shuo Bi, Hongsheng Tian, Xuying Guo, Yuping Zou, Linna Yuan, Wei She, Hongmei Sun, Yu Dong, Chen Zhang, Ye Ma, Zhenwei Shang, Yongshuai Jiang, Wenhua Lv, Hongchao Lv, Mingming Zhang\",\"doi\":\"10.1080/14737140.2025.2555466\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Prostate cancer (PCa) is one of the most common malignancies in males worldwide. Therefore, conducting the latest and comprehensive assessment of PCa is important.</p><p><strong>Research design and methods: </strong>Average annual percent change for age-standardized rate trend was calculated by Joinpoint. Pearson correlation analyzed the relationship between PCa and Sociodemographic Index (SDI). Causal associations of risk factors were examined by two-sample mendelian randomization. Bayesian age-period-cohort model was used to predict incidence trends to 2050.</p><p><strong>Results: </strong>In 2021, the global incidence of PCa was 1,324,383, an increase of 161.53% since 1990. It was mainly concentrated in the age group of 65-79. From 1990 to 2021, the global incidence and prevalence increased slightly. PCa was more common in regions with a high SDI. Mortality was the highest in regions with a low SDI. Smoking and telomere length were found to be risk factors for PCa, and diet low in calcium and milk was also related to PCa. The prediction results revealed that the incidence of PCa will slightly decrease in the future.</p><p><strong>Conclusions: </strong>The disease burden of PCa gradually increased from 1990 to 2021. There were significant differences across countries, SDI regions, and age groups. By 2050, the incidence of this disease is expected to decrease.</p>\",\"PeriodicalId\":12099,\"journal\":{\"name\":\"Expert Review of Anticancer Therapy\",\"volume\":\" \",\"pages\":\"1-10\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-09-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Expert Review of Anticancer Therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/14737140.2025.2555466\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Anticancer Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14737140.2025.2555466","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
Burden trends and risk factors for prostate cancer from 1990 to 2021: a systematic analysis of the Global Burden of Disease Study 2021.
Objectives: Prostate cancer (PCa) is one of the most common malignancies in males worldwide. Therefore, conducting the latest and comprehensive assessment of PCa is important.
Research design and methods: Average annual percent change for age-standardized rate trend was calculated by Joinpoint. Pearson correlation analyzed the relationship between PCa and Sociodemographic Index (SDI). Causal associations of risk factors were examined by two-sample mendelian randomization. Bayesian age-period-cohort model was used to predict incidence trends to 2050.
Results: In 2021, the global incidence of PCa was 1,324,383, an increase of 161.53% since 1990. It was mainly concentrated in the age group of 65-79. From 1990 to 2021, the global incidence and prevalence increased slightly. PCa was more common in regions with a high SDI. Mortality was the highest in regions with a low SDI. Smoking and telomere length were found to be risk factors for PCa, and diet low in calcium and milk was also related to PCa. The prediction results revealed that the incidence of PCa will slightly decrease in the future.
Conclusions: The disease burden of PCa gradually increased from 1990 to 2021. There were significant differences across countries, SDI regions, and age groups. By 2050, the incidence of this disease is expected to decrease.
期刊介绍:
Expert Review of Anticancer Therapy (ISSN 1473-7140) provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches.
Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological therapy, cancer vaccines, therapeutic indications, biomarkers and diagnostics, and treatment guidelines. All articles are subject to rigorous peer-review, and the journal makes an essential contribution to decision-making in cancer care.
Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections:
Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results
Article Highlights – an executive summary of the author’s most critical points.